Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Common Stock and Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling Interests
Balance at beginning of period (in shares) at Dec. 31, 2021		169.6
Balance at beginning of period at Dec. 31, 2021		$ 989	$ (10)	$ (2,379)	$ 1,350	$ 10	$ 17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings					267		1
Other comprehensive income				(5)
Issuance of common stock and stock options exercised (in shares)		1.2
Issuance of common stock and stock options exercised		$ 50
Share repurchase program (in shares)		(2.2)
Share repurchase program					(493)
Share-based compensation expenses		$ 37
Dividends declared					(132)
Balance at ending of period (in shares) at Apr. 02, 2022		168.6
Balance at end of period at Apr. 02, 2022		$ 1,066		(2,384)	1,002		18
Balance at beginning of period (in shares) at Dec. 31, 2021		169.6
Balance at beginning of period at Dec. 31, 2021		$ 989	$ (10)	(2,379)	1,350	$ 10	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 497
Other comprehensive income	(112)
Balance at ending of period (in shares) at Jul. 02, 2022		167.9
Balance at end of period at Jul. 02, 2022		$ 1,112		(2,491)	936		13
Balance at beginning of period (in shares) at Apr. 02, 2022		168.6
Balance at beginning of period at Apr. 02, 2022		$ 1,066		(2,384)	1,002		18
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	229				228		1
Other comprehensive income	(107)			(107)
Issuance of common stock and stock options exercised (in shares)
Issuance of common stock and stock options exercised		$ 2
Share repurchase program (in shares)		(0.7)
Share repurchase program					(162)
Share-based compensation expenses		$ 44
Dividends declared					(132)
Dividends paid to non-controlling interest on subsidiary common stock							(6)
Balance at ending of period (in shares) at Jul. 02, 2022		167.9
Balance at end of period at Jul. 02, 2022		$ 1,112		(2,491)	936		13
Balance at beginning of period (in shares) at Dec. 31, 2022		168.5
Balance at beginning of period at Dec. 31, 2022	131	$ 1,308		(2,535)	1,343		15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings					278		1
Other comprehensive income				48
Issuance of common stock and stock options exercised (in shares)		0.9
Issuance of common stock and stock options exercised		$ 25
Share repurchase program (in shares)		(0.5)
Share repurchase program					(140)
Share-based compensation expenses		$ 55
Dividends declared					(148)
Dividends paid to non-controlling interest on subsidiary common stock							(1)
Balance at ending of period (in shares) at Apr. 01, 2023		168.9
Balance at end of period at Apr. 01, 2023		$ 1,388		(2,487)	1,333		15
Balance at beginning of period (in shares) at Dec. 31, 2022		168.5
Balance at beginning of period at Dec. 31, 2022	131	$ 1,308		(2,535)	1,343		15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	652
Other comprehensive income	$ 88
Share repurchase program (in shares)	(1.3)
Share repurchase program	$ (364)
Balance at ending of period (in shares) at Jul. 01, 2023		168.3
Balance at end of period at Jul. 01, 2023	351	$ 1,451		(2,447)	1,333		14
Balance at beginning of period (in shares) at Apr. 01, 2023		168.9
Balance at beginning of period at Apr. 01, 2023		$ 1,388		(2,487)	1,333		15
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	373				371		2
Other comprehensive income	$ 40			40
Issuance of common stock and stock options exercised (in shares)		0.2
Issuance of common stock and stock options exercised		$ 10
Share repurchase program (in shares)	(0.8)	(0.8)
Share repurchase program	$ (224)				(224)
Share-based compensation expenses		$ 53
Dividends declared					(147)
Dividends paid to non-controlling interest on subsidiary common stock							(3)
Balance at ending of period (in shares) at Jul. 01, 2023		168.3
Balance at end of period at Jul. 01, 2023	$ 351	$ 1,451		$ (2,447)	$ 1,333		$ 14